Boltz PBC is a Public Benefit Corporation with a mission to advance the frontier of AI capabilities in biology through open science and make them universally accessible to every scientist working towards a healthier, more sustainable future.
Today, we are excited to announce some major steps in this direction: the unveiling of our new small-molecule and protein design agents, the launch of Boltz Lab, our seed round, and the announcement of a partnership with Pfizer.
The team is happy to announce that we have received the backing of Zetta, Amplify, a16z, and strategic angels, including Clement Delangue (CEO of Hugging Face), Factorial Capital, and Obvious Ventures with a $28M seed round.